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Summary
Many nervous system pathologies are associated with increased levels of Apolipoprotein D
(ApoD), a lipocalin also expressed during normal development and aging. An ApoD homologous
gene in Drosophila, Glial Lazarillo, regulates resistance to stress, and neurodegeneration in the
aging brain. Here we study for the first time the protecting potential of ApoD in a vertebrate model
organism. Loss of mouse ApoD function increases the sensitivity to oxidative stress and the levels
of brain lipid peroxidation, and impairs locomotor and learning abilities. Human ApoD over-
expression in the mouse brain produces opposite effects, increasing survival and preventing the
raise of brain lipid peroxides after oxidant treatment. These observations, together with its
transcriptional up-regulation in the brain upon oxidative insult, identify ApoD as an acute
response protein with a protective and therefore beneficial function mediated by the control of
peroxidated lipids.
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Introduction
Apolipoprotein D (ApoD) is a Lipocalin, an ancient family of small proteins engaged in a
diverse array of physiological processes, whose general molecular function is binding and
transporting hydrophobic ligands. ApoD is known to bind arachidonic acid, progesterone,
retinol, cholesterol and other lipophilic ligands. Elevations in its expression level have been
associated with a number of pathological and tissue damage conditions including
neurodegenerative diseases. Its levels increase as well during physiological aging (see
Rassart et al. 2000; Van Dijk et al. 2006 for review). Although the correlation between those
states and increased gene expression is consistent, the causal link with ApoD function is still
unclear. Whether ApoD is one of the factors contributing to the degenerative or aging
processes, or its function is part of a defense mechanism providing protection to cells must
be solved.
Our previous work on an ApoD homologue in insects, the Drosophila Glial Lazarillo
(GLaz), shows that it regulates longevity, resistance to stress, locomotor behavior, and
degeneration in brain and other tissues upon aging (Sanchez et al. 2006; see also Walker et
al. 2006). We therefore undertook a genetic analysis of the ApoD function in a vertebrate
model organism by generating knockout and transgenic over-expressing mice.
Results and Discussion
An ApoD knockout mouse (ApoD-KO) was generated by standard homologous
recombination techniques. We replaced the wild-type ApoD gene with a copy interrupted by
the insertion of the neomycin resistance gene (Neo) in the opposite direction to ApoD
transcription (Fig. 1S A), which rendered a transcriptional null mutant (Fig. 1S B–D)
without deleting any genomic fragment potentially containing regulatory regions. We also
generated transgenic mice over-expressing the human orthologue of ApoD (HApoD) under
the control of the neuronal human Thy-1 promoter (HApoD-Tg line; Fig. 2S A), thus
expressing HApoD in neurons in all regions of the nervous system (Fig. 2S B–E). General
features of ApoD-KO and HApoD-Tg mice are described in Supporting Information
available online.
Both ApoD-KO and HApoD-Tg mice are viable and breed normally. Three independent
lines were obtained for the Thy-1 transgenic, but a single line was used in this work due to
their similar phenotypes based on general health, and biochemical and molecular
characterization (Do Carmo & Rassart, unpublished observations). No apparent genotypic
differences were observed during development when comparing sibling ApoD-KO and WT
mice (see Supporting Online Information). We therefore turn to study ApoD function during
adulthood, both in normal conditions, and when exposing the organism to oxidative stress
situations mimicking the many pathological situations in which ApoD is up-regulated.
ApoD alters locomotor activity and learning abilities in young adult animals
Open field analysis revealed a significant decrease in horizontal and vertical locomotor
activity in ApoD-KO mice (25% and 36% mean reduction in horizontal and vertical activity
respectively; Fig. 1A, left and right panels), while no differences were observed in anxiety
related parameters (relative time spent in the center vs. periphery of the open field arena;
Fig. 1A central panel). On the other hand, over-expression of human ApoD causes an
increase in vertical activity (number of rearings, Fig. 1B, left panel), while differences in
horizontal activity were not significant (Fig. 1B, right panel).
Visual ability, assessed by darkness preference and object recognition, was not significantly
affected. Other behavioral tests exploring pain and touch sensitivity, gait, and muscular
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strength gave no significant differences between ApoD-KO mice and their wild-type
littermates. Similarly, the walking pole test exploring sensory-motor coordination gave no
differences in ApoD-KO nor HApoD-Tg mice (see Supporting Online Material).
ApoD-KO mice and their wild-type control perform equally well in the Rotarod test (also
exploring sensory-motor coordination) when first tested on the accelerated rod after a set of
training sessions. However, a parameter that estimates the ability to learn a motor task
(improvement of performance over consecutive trials) was much smaller in the ApoD-KO
mice (Fig. 1C).
Hippocampal-dependent memory was assessed with the spatial version of the Barnes maze.
Wild-type mice showed an average learning time of 64 days, while none of the ApoD-KO
mice were able to meet the learning criteria (7 out of 8 sessions with 3 or less errors) for the
test period of 70 days (Fig. 1D).
Therefore, mice lacking ApoD expression reduce their locomotor and exploratory activity,
while over-expression of HApoD in the brain renders the animals slightly more active. In
addition, ApoD-KO mice show deficits in learning either a motor task or an orientation-
based task (dependent on visual cues). Decreased locomotor performance was also shown
for Drosophila GLaz null mutants (Sanchez et al. 2006), illustrating interesting functional
conservation of these homologous genes throughout evolution.
Resistance to experimentally induced oxidative stress is undermined in the absence of
ApoD and increased by the over-expression of human ApoD
The regulation of ApoD in physiological and pathological states where reactive oxygen
species (ROS) are generated (reviewed in Rassart et al. 2000), and the higher sensitivity to
oxidative stress experienced by the Drosophila GLaz mutants (Sanchez et al. 2006)
motivated us to test the overall survival of ApoD-KO and HApoD-Tg mice exposed to an
oxidative insult. Sensitivity to the ROS generator 1,1’-dimethyl-4,4’-bypiridinium (paraquat;
PQ) was assayed using different paradigms of intraperitoneal injections (see Methods in
Supporting Online Material). The ApoD null mutant mice show a higher sensitivity to PQ-
induced chronic oxidative stress than wild-type controls (Fig. 2A). The survival curves show
a reduction in both the median and the maximum lifespan (26% and 56% respectively, Fig.
2A) reflecting an early onset of functional decline in the ApoD-KO mice. This effect is
observed independently of the genetic background (C57BL6/J or Balb/C), indicating that the
reduction observed is originated by the lack of ApoD.
These results will predict that mice over-expressing ApoD would be more protected against
the stress produced by PQ. Indeed, HApoD-Tg mice showed improved survival upon single
systemic exposures to PQ at two different concentrations, with an increase in median
survival time of 41.6 and 27.5% respectively (Fig. 2B,C). Thus the human ApoD protein is
able to exert a protective role when expressed in the mouse brain. This general effect on
survival might be due to either the presence of the neuron-expressed ApoD in the systemic
circulation, or to low levels of non-neuronal ApoD expression in other tissues.
The protective effect of ApoD is also consistent with the results obtained in Drosophila
over-expressing the endogenous ApoD homologue GLaz (Walker et al. 2006) or the human
ApoD gene (Muffat et al. personal communication). All these results strongly suggest that
the protecting role in oxidative stress-compromised survival is a common factor in all ApoD
homologues, reflecting that it is probably part of the ancestral function of this lipocalin.
Therefore, the analyses in model organisms can be very useful to understand the human
ApoD function.
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ApoD expression is induced in the brain upon experimental oxidative stress
The up-regulation of ApoD in ROS-related pathological conditions predicts that an
experimentally produced oxidative stress would also regulate ApoD mRNA expression in
the mouse. Since ApoD is up-regulated in neurological pathologies, and our behavioral
studies in the mouse indicate that nervous system functionality is compromised in the
absence of ApoD, we assayed the transcription of ApoD in mouse brain after a single
exposure to PQ. An acute up-regulation of ApoD (1.86-fold induction) is detected 3 hours
after exposure, and the expression returns to baseline by 24 hours (Fig. 3A). Similar
transient effects of PQ on gene transcription have been shown in lung and kidney for several
genes with antioxidant roles (Tomita et al. 2006a;Tomita et al. 2006b). We therefore
assayed the transcription of ApoD in several tissues 3 hours after PQ exposure, when the
expression peaks in the brain. No up-regulation is produced in the lung or the liver, while
the brain tissue shows a strong ApoD induction upon PQ treatment (Fig. 3B). These results
suggest a specific function of ApoD in the response of the nervous system to oxidative
injury.
The higher sensitivity to oxidative stress of mice lacking ApoD parallels our results obtained
in the Drosophila GLaz null mutant (Sanchez et al. 2006) and in null mutants of the ApoD
homologue in plants (Frenette-Charron et al. personal communication) which are more
sensitive to oxidative and other forms of stress. We can therefore predict that the regulation
of these lipocalin genes must also be conserved (a transient up-regulation of GLaz also
occurs in Drosophila, our unpublished observations also confirmed by J. Muffat et al.
personal communication), and that the ApoD up-regulation in the mouse brain upon PQ-
induced ROS generation is part of the normal protective response to stress.
The increased survival of the transgenic animals over-expressing human ApoD in the
nervous system should be due to a higher and longer-lasting presence of ApoD in the
tissues. Since the human transgene is placed in a wild-type genetic background (C57BL6/J
mice), we measured the expression level of the mouse endogenous ApoD gene in the brain
of transgenic animals. Mouse ApoD transcript levels are not affected by the presence of the
human transgene either under normal conditions or upon PQ treatment. As expected, the
human transgene does not show a response by PQ (Fig. 3C).
ApoD controls the levels of brain lipid peroxidation under normal conditions
PQ treatment is known to generate protein and lipid peroxidation (Beal 2002). By evaluating
the oxidation state of these macromolecules in the brain, both in the control situation and in
the presence of PQ-induced oxidative stress, we should gain insight into the biochemical
actions of ApoD in the brain tissue when it is exerting the protecting effects described above
at the organism level.
We assayed lipid peroxidation levels upon the different paradigms used for PQ injection. In
agreement with McCormack et al. (McCormack et al. 2005), lipid peroxide adducts
accumulate in the wild type brain over time at a relatively slow pace (Fig. 3S A). As it is the
case for tissues like lung, kidney and liver (Sato et al. 1992), no increase in lipid
peroxidation is observed in the brain 3 hours after a single high dose of PQ (acute PQ
treatment, protocol B), while a low-dose chronic treatment (protocol C) does produce a
significant increase after two weeks. In contrast, protein carbonylation, a marker of
oxidative modification of proteins, is much faster, showing a patent increase by 3 hours
upon acute treatment (Fig. 3S B).
In control conditions (sham injection, Fig. 4A) we observe that the lack of ApoD results in
increased levels of lipid peroxides in the brain, but not in the lung, in accordance with the
normal tissue distribution of ApoD. Moreover, as expected for a lipid managing lipocalin,
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the effect is specific for lipids, since no alterations are seen in protein carbonylation. On the
other hand, the amount of lipid peroxidation in the brain of HApoD-Tg mice is similar to the
wild-type levels (Fig. 4C), indicating that an excess of human ApoD cannot reduce the basal
levels of oxidation products related to normal cellular metabolic activity. As expected, lung
lipid peroxidation levels are also unchanged by the human transgene (not shown).
An increased level of lipid peroxidation under basal conditions was also observed in the
GLaz null mutant fruit flies (Sanchez et al. 2006). These results suggest that ApoD and its
homologues can condition the peroxidation state of lipids, even in normal non-stress
situations. The maintenance of cellular membrane integrity can be expected to be
compromised in the ApoD-KO and, since ApoD absence is particularly noticed in the brain,
it can result in neural functional alterations that we are able to detect by behavioral tests.
The data by Thomas and Yao (Thomas & Yao 2006) also support the above proposal. They
performed a brain lipid profile analysis in our ApoD-KO mice to understand the role of
ApoD in the mechanisms of antipsychotic drug action. Their results in the control animals
(without drug addition) show that ApoD-KO brains have increased levels of some
polyunsaturated fatty acids (dienes and hexanenes). Since polyunsaturated fatty acids are
more prone to peroxidation, the susceptibility of membranes to peroxidation (Hulbert 2005)
must be increased in the ApoD-KO brains, and therefore membranes could be more
susceptible to the effects of normal oxidative metabolism.
ApoD is able to prevent the lipid peroxidation increase upon oxidative insult
Upon oxidative insult (either acute or low-dose chronic PQ treatment) lipid peroxidation
increases (33% and 43% respectively) over the wild-type levels in the ApoD-KO brain (Fig.
4B). This change can be correlated with the decrease in survival time observed in the ApoD-
KO mice upon PQ treatment.
Again, no genotype-dependent differences in protein carbonylation were observed under PQ
treatment (Fig. 4B), suggesting that the function of ApoD is confined to lipid management.
On the other hand, human ApoD over-expression abolishes the long-term accumulation of
lipid peroxides after 2 weeks of PQ treatment, maintaining the levels at control values (Fig.
4C).
These results show that an excess of human ApoD in the brain can counteract the
exogenously-induced oxidative damage to lipids. Therefore, we can expect that a
supplement of ApoD might be beneficial for human conditions where lipid oxidation is a
key factor in the functional decline associated to physiological aging or neural pathologies.
Lipocalins as part of the oxidative stress response system
Our data support the notion that ApoD is part of the mechanisms regulating protection from
diverse forms of stress, including oxidation.
We show in this report that ApoD specifically controls the levels of lipid peroxidation in an
organ as vulnerable as the brain. The structural property of ApoD shared with all other
lipocalins is the presence of a binding pocket that can bind diverse molecules, mostly
hydrophobic (Flower et al. 2000; Akerstrom et al.. Eds.) (2006), therefore it is probable that
its mechanism of action involves this lipid-binding property. The control of lipid
peroxidation can be exerted directly, either a priori by preventing the oxidation of bound
lipids, or a posteriori by removing peroxidated lipids from membranes, and therefore
avoiding the positive feedback loops leading to more oxidative damage. Alternatively, the
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control of lipid oxidation can be a consequence of the regulation of lipid composition in
membranes, which will determine the susceptibility of membranes to peroxidation.
Scavenging roles have been proposed for other lipocalins. Lcn-1 (tear lipocalin), expressed
in secretory glands, has been shown to bind lipid peroxidation products in vitro and is also
up-regulated upon oxidative stress in an epithelial cell line (Lechner et al. 2001). α-1
microglobulin is able to reduce and then trap ABTS radicals by covalent binding (Akerstrom
et al. 2007).
However, can our data also be compatible with a direct antioxidant activity of ApoD?
The antioxidant defense system is currently known to comprise low molecular mass agents
(e.g. glutathione or melatonin), iron or copper sequestration proteins (such as transferrin,
ferritin, or albumin) and antioxidant enzymes (like superoxide dismutase or catalase). With
the data available so far, ApoD belongs to none of these categories. While other lipocalins
are well known for their iron sequestration properties (Goetz et al. 2002; Flo et al. 2004),
binding to toxic heme (Allhorn et al. 2002) or antioxidant catalytic activities (Allhorn et al.
2005), neither metal sequestration properties nor enzymatic activity have been shown for
ApoD, or its orthologues in fruitflies or plants.
The lipocalin α-1 microglobulin (Allhorn et al. 2002; Allhorn et al. 2005; Akerstrom et al.
2007) exerts reductase and dehydrogenase activities through a free cysteine group located in
a flexible loop. ApoD has four cysteine residues that form two disulfide bonds at the core of
the protein fold in all species studied so far. However, human ApoD has an extra cysteine
(Cys116) known to bind covalently to Apolipoproteins A-II and B-100 (Blanco-Vaca et al.
1992). Whether the thiol group of Cys116 confers additional antioxidant properties to
human ApoD remains to be investigated. If this were the case, then this property would be
human-specific. In order to explain the results obtained in mouse (this study), fly (Sanchez
et al. 2006) and plants (Frenette-Charron et al. personal communication), additional
antioxidant properties of ApoD that are conserved among these divergent species must be
invoked. Moreover, the fact that only lipid peroxidation, but not protein carbonylation, is
altered in the absence of ApoD argues against a direct antioxidant activity of mouse ApoD.
The oxidative modification of membrane lipids also triggers intracellular signaling cascades
that direct the cell fate after an oxidative insult. Particularly, arachidonic acid (AA) is known
to be mobilized from membranes upon oxidative stress (Balboa & Balsinde 2006). ApoD is
able to bind a variety of lipidic ligands (Rassart et al. 2000; Breustedt et al. 2006; Eichinger
et al. 2007) of which the highest affinity is shown for AA. Data supporting the participation
of ApoD in regulating the mobilization of AA has been shown in a cell culture system
(Thomas et al. 2003b), and both ApoD and AA are regulated in patients with schizophrenia
in response to antipsychotic drug treatment (Thomas et al. 2001; Thomas et al. 2003a). The
lipid analysis of ApoD-KO brains upon treatment with clozapine (Thomas & Yao 2006) has
shown that the absence of ApoD alters the levels of AA upon drug treatment (even though
levels are not modified by the mutation in basal conditions). Thus by modulating important
signaling lipids like AA, ApoD can influence the patient’s response to different treatments.
All data available so far point to a common biochemical function for ApoD, directly linked
to membrane physiology, which is essential for a proper nervous system function. By
controlling the levels of lipid peroxidation ApoD could influence parameters as important as
neurotransmitter release, in turn affecting learning abilities or locomotor activity
(Vajragupta et al. 2000) throughout life. Likewise, by performing the same biochemical
function, ApoD can control the rate of brain functional decline upon normal aging or in
pathological conditions, although it is unlikely to be the only such factor.
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Functional significance of ApoD: its influence on normal and pathological nervous system
decline upon aging
We have shown that ApoD expression in the mouse brain is boosted by experimental
oxidative stress, mimicking what happens in many human neurodegenerative and psychiatric
diseases, nervous system injuries, as well as during normal aging. The main known effect of
lacking ApoD is to become more vulnerable to stress, while an ApoD overdose makes
animals less sensitive to the same stress. The fact that the human ApoD gene can produce
effects that oppose those observed in the ApoD-KO mouse strongly suggests a conserved
function, and therefore the utility of the mouse model to test potential therapeutic uses of
ApoD. This study is the first showing that an excess of ApoD results in seemingly beneficial
effects upon experimental oxidative stress in the mouse. Testing the effects of over-
expressing ApoD in mouse models of disease should therefore become a priority.
Experimental procedures
Animals
The experimental procedures were approved by the Animal Care and Use Committees of the
University of Utah, University of Valladolid and Université du Québec à Montréal, and were
in accordance with the Guidelines for the Care and Use of Mammals in Neuroscience and
Behavioral Research (2001). Mice were maintained in positive pressure-ventilated racks at
25±1°C with a 12 h light/dark cycle, fed a standard rodent pellet diet (Global Diet 2014;
Harlan), and allowed free access to filtered and UV-irradiated water. Experiments were
carried out with 3–5 months old animals of mixed sexes.
Targeted disruption of the mouse ApoD gene
In order to silence the mouse ApoD gene we constructed a targeting vector with the
neomycin phosphotransferase (Neo) gene interrupting exon 6 of the ApoD gene (Fig. 1S A).
G418r-GANCs 129/SvJ ES cells were transfected with the construct and tested for the
presence of the disrupted ApoD allele by BamHI digestion of their genomic DNA followed
by Southern hybridization with an external probe comprising exon 4 (Fig. 1S A). Genomic
DNA sequence of the region surrounding the targeting vector confirmed the proper
homologous recombination of the positive lines injected into female mouse blastocysts at
the U. of Utah Transgenics Facility. Subsequent crosses with the chimeric mice showing
germline transformation of the targeted allele generated heterozygous ApoD+/− mice that
were further confirmed by Southern blot with a 3’ probe (Fig. 1S A). Standard genotyping
was performed from tail DNA and PCR with Neo and ApoD-specific primers: ApoD-for: 5’
CCA CCG GCA CCC TAC TGG ATC 3’; ApoD-rev: 5’ CGG GCA GTT CGC TTG ATC
TGT 3’; and Neo-for: 5’ CGA TTG TCT GTT GTG CCC AGT 3’.
Phenotype stability was assessed by backcrossing and outcrossing the ApoD mutated allele
into the C57BL6/J and Balb/C genetic backgrounds respectively. The mutant allele was
selected for ten generations of crosses with the corresponding wild type females. An
additional generation was performed by crossing mutant females with wild type males to
introduce the Y chromosome of the wild type strain.
Generation of human ApoD transgenic mouse
The human ApoD transgenic mouse (HApoD-Tg) carries a construct (~ 4.5 kb) containing
the promoter, the first exon, the first intron and the 5’ non-coding region of the second exon
of the human Thy-1 gene (generous gift from J. Silver, New York University Medical
Center). This fragment was fused to the human ApoD coding sequence followed by the
bovine growth hormone (BGH) polyadenylation signal (Fig. 2S A). The presence of the
transgene was verified by PCR using an ApoD-specific primer (5’ CCC AAT CCT CCG
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GTG CAG GAG AA 3’) and a BGH-specific primer (5’ GAA GGC ACA GTC GAG GCT
GAT CAG 3’), producing a 0.6 kb fragment (Fig. 2S B). The HApoD-Tg mice used in this
study were backcrossed onto C57/BL6 wild-type mice as explained above.
RNA extraction and northern blot analysis
Animals were euthanized by inhalation of CO2/O2 (2:1). Tissues were collected, frozen in
dry ice, and kept at −80°C until extraction of total RNA using the Trizol reagent™
(Invitrogen). Total RNA (10µg) was separated on 1.5% (wt/vol) agarose-formaldehyde gels
and blotted to a nylon membrane. The membranes were hybridized with [α-32P]dCTP-
labeled mouse or human ApoD, or GAPDH cDNAs, exposed to Biorad Imaging screen K
and revealed with a PhosphorImager (Biorad Molecular Imager FX) and Quantity One
software (Biorad). For each value, the optical density measured for each gene tested was
divided by that of the GAPDH mRNA.
Protein extraction and western blot analysis
Frozen tissues were thawed on ice and homogenized in lysis buffer (50 mM Tris-HCl pH
7.3, 150 mM NaCl, 5 mM EDTA, 0.2% Triton X-100, and 10% Complete protease
inhibitors (Roche)). After 30 min of incubation at 4°C, lysates were sonicated and cleared by
centrifugation. The protein concentration was determined using a protein assay reagent (Bio-
Rad Laboratories). All extracts were stored at −80°C.
For western blot analysis, protein extracts (10µg) were separated on a 12% SDS-
polyacrylamide gel and transferred to a polyvinylidene difluoride (PVDF) membrane. A
prestained size marker (Biorad prestained SDS-PAGE standard, low range) was included in
each run. Membranes were blocked in PBS containing 0.2% Tween-20 and 5% skim milk
powder before incubation with the primary antibodies diluted as follows: polyclonal anti-
human ApoD (Caro2), 1:4000; anti-GAPDH, 1:4000. Subsequently, the blots were
incubated under gentle agitation at room temperature with a HRP-conjugated secondary
antibody diluted 1:5000 in blocking buffer. The blots were developed using the enhanced
chemoluminescence method (Amersham-Pharmacia) with X-ray film.
Behavioral analyses
Open field tests in the ApoD-KO and their wild type controls were performed by video
recording in a 1m2 arena for a single session of 10 min. A total of 6 mice of each genotype
and sex were analyzed. The subsequent analysis explored horizontal (Number of squares
visited) and vertical (Number of rearings) activities, as well as anxiety, measured as relative
time spent in the central area of the arena. Horizontal and vertical activity was measured in
the HApoD-Tg mice and control littermates in an open field arena measuring 30 × 44.5 cm.
A novel-object recognition test was used to assay for visual ability and short-term memory
recognition. Mice habituated to the test arena are presented with two plastic objects of
different shapes. The object recognition was evaluated by the ratio of time spent exploring
the novel vs. the familiar object 10 sec and 1 min after first exposure.
Hippocampal-dependent memory was explored in six WT and six ApoD-KO mice subjected
to the spatial version of Barnes maze test (Barnes 1979), where the mouse needs to learn and
remember distal cues in the environment, and associate them with the location of an escape
tunnel. The mice were tested daily for 70 days, and the number of holes searched,
perseverations and time was recorded. The average for each genotype was recorded and
grouped into session blocks of 5 testing days.
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Rotarod analysis was performed in a Ugo Basile (Varese, Italy) apparatus with acceleration
from 4 to 40 rpm over 5 minutes. Each mouse was subjected to two training sessions
separated by a 15 min rest. Each session consisted of a 2 min period of exposure to the rod
rotating at minimum speed (4 rpm). After another 15 min resting period a first test was
performed, consisting of three runs with the rod accelerating from the starting 4 rpm speed.
Time of permanence in the rod was recorded. A second test of three runs was performed 2
hours later, after the mice had been injected intraperitoneally either with PBS or paraquat
(see Protocol B below).
Other tests such as pain and touch sensitivity, gait, and muscular strength were performed as
detailed in (Crawley 2000).
Oxidative stress toxicity by 1,1’-dimethyl-4,4’-bypiridinium (paraquat)
The following protocols of doses, administration patterns and analysis have been used:
Protocol A—Chronic paraquat (PQ) treatment. Mice were daily injected intraperitoneally
with a solution of PQ in phosphate buffered saline (PBS) at 15 mg/kg of body weight. Death
occurrence was scored at least every 12 hours for the survival analysis. Morphological
analyses were performed on brains from mice euthanized on day 5 of treatment (when the
ApoD-KO mice survival is at the 50% level).
Protocol B—Acute PQ treatment. A single dose of either 30 or 50 mg/kg of PQ was
injected as described above. Behavioral tests were performed just before injection (t =0), 1.5
hours after injection, and 24 hours after injection. Mice were then euthanized either 3 hours
or 24 hours post-injection, and their brains extracted for biochemical and
immunohistochemical analyses.
Protocol C—Low-dose, neurotoxic chronic PQ treatment. Following Thyruchelvam et al.
(Thiruchelvam et al. 2000), mice were injected twice a week, for a total of 2 weeks, with a
15 mg/kg of PQ as described before. Animals were euthanized 3 hours after the last
injection, and their brains extracted for biochemical and immunohistochemical analyses. We
confirmed the absence of lung toxicity by histopathological analysis looking for alterations
in alveoli, respiratory ducts, and bronchioles (results not shown).
Lipid and protein oxidation assays
TBARS assay—The concentration of thiobarbituric acid (TBA) reactive species was
assayed to monitor the level of lipid peroxidation. Brain tissue was homogenized in PBS in
the presence of an antioxidant (butylated hydroxytoluene, BHT) to prevent new lipid
peroxidation to occur during homogenization. A 12µl aliquot of each extract was incubated
with 390µl of 0.2 M glycine-HCL, pH 3.6 and 250µl of fresh TBA reagent (0.5% TBA,
0.5% SDS). After 15 min incubation at 90°C, samples were cooled on ice and transferred to
a 96 well microplate for triplicate readings. Absorbance was monitored at 532 nm in a
Versamax microplate reader (Molecular Devices). Values were normalized to the protein
concentration of each sample, measured with the Micro BCA Protein Assay (Pierce).
Protein carbonylation-ELISA assay—Protein carbonylation was performed as
previously reported (Buss et al. 1997). Briefly, triplicate protein samples were allowed to
react with dinitrophenylhydrazine (DNP) and then adsorbed to wells of an ELISA plate. A
biotinylated anti-DNP antibody (Molecular Probes Inc.) was used for detection of the
protein-bound DNP followed by an amplification step with streptavidin-biotinylated
horseradish peroxidase (Amersham). Color reaction was performed by supplying o-
phenylenediamine, hydrogen peroxide and citric acid in phosphate buffer. Absorbance at
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490 nm was measured in a Versamax microplate reader (Molecular Devices). Values were
normalized to the protein concentration of each sample.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Alterations in behavioral output in ApoD-KO and HApoD-Tg mice
(A) Open field test on locomotor exploratory behavior in ApoD-KO mice. Both horizontal
(number of squares visited) and vertical (number of rearings) activities are decreased in the
ApoD-KO mice, while an anxiety-related behavior (exploration of the center of the 1 m2
arena) is not altered. N= 12 mice/genotype (6th backcross generation onto C57BL/6
background). Unpaired two-sided Student’s t-test, *p < 0.05, **p < 0.01.
(B) Open field test in HApoD-Tg mice. Vertical activity increase in HApoD-Tg mice (left
panel), while horizontal activity differences are not significant (right panel). A smaller arena
was used in this case, and the anxiety parameter was not measured. WT: N = 16; HApoD-
Tg: N = 13 (11th backcross generation onto C57BL/6 background). Unpaired two-sided
Student’s t-test, *p < 0.05.
(C) Motor learning abilities were tested as the increment of the Rotarod test score over a 2
hours interval, and is represented normalized to the score of the first test. ApoD-KO mice
show a lower learning ability under normal conditions. N= 14 mice/genotype (11th
backcross generation onto C57BL/6 background). Sign non-parametric test, *p < 0.05.
(D) Barnes maze test on spatial learning. ApoD-KO mice fail to increase their rate of
success in finding a safe escape hole, while wild type mice learn and remember using distal
spatial clues. Mice were tested daily for 70 days. Results from each five consecutive daily
sessions were combined in blocks. N= 6 mice/genotype (5th backcross generation onto
C57BL/6 background). ANOVA test, p < 0.0001.
(A–D) Data are represented as mean ± SD.
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Figure 2. Oxidative stress-compromised survival is decreased in the absence of ApoD and
increased when human ApoD is over-expressed in the mouse brain
(A) Survival analysis of mice treated daily with the ROS generator paraquat (15 mg/kg of
body weight; Protocol A). KO and WT genotypes in C57BL/6 background (8th backcross
generation) are compared. N= 11 mice/genotype. The absence of ApoD shortens the mice
survival (Gehan-test, p = 0.026; Cox’s F-test, p = 0.028). A decrease of 26% in mean
lifespan and 56% in maximum lifespan is observed. The survival phenotype is stable after
changing the genetic background (Balb/C, 8th outcross generation) with 11% decrease in
mean lifespan and 9% in maximum lifespan. N= 12 mice/genotype. Gehan-test, p = 0.031;
Cox’s F-test, p = 0.043 (curve not shown).
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(B and C) Survival analysis of WT and transgenic (HApoD-Tg) mice treated with single PQ
doses of 30 (B) or 50 (C) mg/kg of body weight (Protocol B). Death occurrence was
recorded up to 10 days. Surviving animals were sacrificed at day 10. Data was fitted to a
Gompertz function. (B) Over-expression of ApoD increases the mice survival. WT: N = 16;
HApoD-Tg: N = 13. Gehan-test, p = 0.029; Cox’s F-test, p = 0.043. (C) Over-expression of
ApoD also protects mice at higher doses of paraquat. WT: N = 12; HApoD-Tg: N = 9.
Gehan-test, p = 0.045; Cox’s F-test, p = 0.033. All transgenic mice are backcrossed on the
C57Bl/6 background (11th generation).
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Figure 3. The endogenous mouse ApoD is transiently up-regulated by exposure to PQ while the
human transgene is expressed constitutively in the brain
(A) Northern blot analysis of mouse ApoD mRNA shows a transient increase in response to
a single injection of paraquat (30 mg/kg; Protocol B). Quantification of mRNA expression
by band densitometry. Values were normalized with the GAPDH gene. Error bars represent
SD (N=3).
(B) Mouse ApoD is specifically up-regulated in the brain upon acute PQ treatment (3 hours
after a single PQ dose; 30mg/kg; Protocol B). No induction is observed in liver or lung. The
GAPDH gene was used as a control.
(C) Northern blot analysis shows a comparable expression of the mouse ApoD endogenous
mRNA in the brain of WT and HApoD-Tg mice 3 hours after a single PQ dose (30mg/kg;
Protocol B), and the absence of response to PQ of the human transgene. The GAPDH gene
was used as a control.
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Figure 4. Loss of ApoD function specifically alters lipid peroxidation in the brain and an over-
dose of human ApoD prevents their accumulation upon oxidative insult
(A) Oxidation of proteins (Carbonyls-ELISA assay) and lipids (TBARS assay) in control
conditions (sham injection of PBS). Lipid peroxidation, and not protein carbonylation, is
increased in the ApoD-KO brains, while lipid peroxidation in the lung remains unchanged.
(B) Brain oxidation status assayed upon acute (3 hours, Protocol B) or chronic (2 weeks
low-dose, Protocol C) exposure to paraquat. ApoD-KO mouse brain show a higher level of
lipid peroxidation while protein carbonylation levels do not change with genotype.
(A and B) N= 7 mice/genotype/sex (11th backcross generation onto C57BL/6 background).
Data are represented as mean ± SD normalized to the wild-type value. Unpaired two-sided
Student’s t-test, *p < 0.05, **p < 0.01 ***p < 0.001.
(C) Analysis of lipid peroxidation two weeks after PQ treatment (30 mg/kg of body weight).
Human ApoD expression prevents the rise of oxidized lipids accumulation in the brain. WT:
N = 16; HApoD-Tg: N = 13 (11th backcross generation onto C57BL/6 background).
Unpaired two-sided Student’s t-test, ***p < 0.001. Data are represented as mean ± SD
normalized with respect to the control values (sham injection of PBS).
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